Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review
- 29 February 2008
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 51 (2), 199-211
- https://doi.org/10.1053/j.ajkd.2007.10.040
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Aldosterone breakthrough during therapy with angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathyNephrology, 2006
- Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathyKidney International, 2006
- Podocyte Injury Underlies the Glomerulopathy of Dahl Salt-Hypertensive Rats and Is Reversed by Aldosterone BlockerHypertension, 2006
- Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertensionThe American Journal of Cardiology, 2004
- Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic HypertensionHypertension, 2003
- Aldosterone: A Mediator of Myocardial Necrosis and Renal ArteriopathyEndocrinology, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?The Lancet, 1998
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995